Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 659-667, April 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levi, E.
Right arrow Articles by Fisher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levi, E.
Right arrow Articles by Fisher, J.

The Activity of Tolerant Antileukemia Sera

I. In Vivo Effects1

Elaine Levi, Richard Golden2, Rachel Zerubavel and Joan Fisher

Immunology Laboratory, Medical Research Institute, Cedars-Sinai Medical Center, Los Angeles, California

Neonatal Dutch rabbits were rendered immunologically tolerant to normal AKR/J mouse tissue. The subsequent immunization of these rabbits with the same types of tissues from AKR/J mice which had spontaneously developed a frank lymphatic leukemia produced antisera which were unique in having minimal mouse toxicity combined with strong antileukemia activity. Anti-normal tissue sera and antileukemia sera formed after the immunization of rabbits not pretreated with normal tissue as neonatals, or antisera from rabbits tolerant to normal tissue, immunized with normal tissue, differed markedly in their murine toxicity and antileukemia effects. Antibodies specific to leukemic antigens are implicated by this work.

1 This work was supported by Grant E-330 from the American Cancer Society.

2 Predoctoral Fellow of USPHS, Summer, 1964.

Received 12/16/64. Revised 9/13/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.